Industry News

Marken announces a new depot in Russia and makes a senior appointment.

The Waters ACQUITY QDa Detector is a mass detector designed to bring high-quality, mass spectral data to chromatographic separations.

Advanced Biosciences Laboratories will support the development and production of a novel Shigella vaccine candidate for PATH.

Malvern Instruments has acquired NanoSight, the UK-based nanoparticle characterization company.

he CMO Gallus BioPharmaceutical has acquired the biologics CMO Laureate Biopharmaceutical Services.

The first part of CPhI’s Annual Expert Industry Report examines ADCs, single-use technology, and regulatory failure.

Cambridge Major Laboratories and AAIPharma Services plan to merge to form a global supplier of integrated CMC services.

DSM Pharmaceutical Products appoints a new CEO and President.

Ablynx and AbbVie sign license agreement for Anti-IL-6R Nanobody, ALX-0061 to treat inflammatory diseases.

Cedarburg Hauser Pharmaceuticals has upgraded its API plant in Wisconsin.

Catalent Applied Drug Delivery Institute appoints Claus-Michael Lehr to advisory board.

West Pharmaceutical Services opens its second manufacturing plant in China to expand presence in Asian markets.

Perrigo appoints Keith Webber as head of regulatory review.

J&J's Janssen and PATH partner to improve drug formulation that could help prevent HIV infection.

ATMI has invested in sterile-connector and sterile-fill technology developed by Medical Instill Technologies.

Coldstream Laboratories partners with the National Cancer Institute for developing parental dosage forms for cancer drugs.

Merck & Co. has received a Complete Response Letter from FDA for the resubmission of its new drug application for sugammadex sodium injection.

Covance launches external laboratory-management services for clinical trials.

Almac introduces a web-based tool for clinical-trial drug-supply management and refrigerated reusable shippers for clinical supplies.

GE Healthcare Life Sciences announced that it will build a KUBio modular biopharmaceutical factory in China for JHL Biotech.

Aesica Pharmaceuticals has built a new high-capacity manufacturing facility specifically for the production of solid dose medications used in the treatment of type II diabetes at its UK site in Queenborough, Kent.

GSK reported that the Court of Appeals has ruled against Pronova Biopharma Norge AS in its patent litigation regarding Lovaza.

Takeda Pharmaceutical and Arbor Pharmaceuticals enter into a license, development and commercialization agreement for Edarbi (azilsartan medoxomil) and Edarbyclor (azilsartan medoxomil and chlorthalidone).

ScinoPharm Taiwan will provide commercial manufacturing of the API topiramate to Supernus Pharmaceuticals.

Theorem Clinical Research?s alliance with Charles River Laboratories will provide nonclinical testing programs in the areas of bioanalysis, immunogenicity, and immunology.

AstraZeneca and Merck & Co. form a licensing agreement for Merck?s oral small-molecule drug for ovarian cancer.

Sanofi withdraws its new drug application (NDA) in the US for lixisenatide and plans to file a NDA in 2015.

Unilife grants Sanofi long-term exclusivity for the use of Unilife?s prefilled syringe with Sanofi?s Lovenox.

Columbia Laboratories acquires Molecular Profiles in multimillion-dollar deal.

AMRI reported that Thomas E. D'Ambra, PhD. will retire as president and CEO.